Phase III, Randomized, Multicenter, Open Label, Non-Inferiority Trial to Explore the Safety and Efficacy of Ticagrelor Compared With Clopidogrel in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis

Trial Profile

Phase III, Randomized, Multicenter, Open Label, Non-Inferiority Trial to Explore the Safety and Efficacy of Ticagrelor Compared With Clopidogrel in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Dec 2017

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes
  • Focus Adverse reactions
  • Acronyms TREAT
  • Most Recent Events

    • 30 Nov 2017 Planned End Date changed from 1 Aug 2018 to 1 Dec 2018.
    • 30 Nov 2017 Status changed from recruiting to active, no longer recruiting.
    • 12 Jul 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top